GoldenGolden
Advanced Search
GM&C Life Sciences Fund

GM&C Life Sciences Fund

A venture capital firm in Cheshire that focuses on life science businesses.

GM&C Life Sciences Fund is a venture capital firm in Cheshire that focuses on life science businesses. It is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures"). It is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships. Founded 2015 in Alderley Edge, Cheshire, United Kingdom, it invests in seed rounds, angel rounds and venture rounds. Its portfolio companies include AMR Centre, Acea Health, Biorelate, Clin-e-cal, CLYZ Labs, Manchester Imaging, Maxwellia, Pencil Biosciences and Renephra. As of March 2020, GM&C Life Sciences Fund has made 27 investments. Their most recent investment was on December 12, 2019, when Pencil Biosciences raised £500K.

Timeline

People

Name
Role
LinkedIn

Chris Spencer

Venture Partner

David Whitcombe

Tony Flinn

Venture Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

AMR Centre

Acea Health

Biorelate

Clin-e-cal

CLYZ Labs

Manchester Imaging

Maxwellia

Pencil Biosciences

Renephra

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.